The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...

An alarming outbreak of Guillain Barre Syndrome (GBS) has been reported in Maharashtra, with 101 people ill and one fatality.

Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

MUMBAI (Reuters) -- One person is believed to have died in India's Maharashtra state in an outbreak of Guillain-Barre syndrome (GBS) -- a neurological disease that causes numbness, weakness and pain - ...

India's first Guillain-Barre Syndrome death reported in Maharashtra—what’s causing the outbreak, who’s at risk. Read on to ...

Guillain Barre Syndrome (GBS), a post-infectious neurological disease, is spreading in Pune with over 100 cases reported. A ...

Around 59 people have been diagnosed with Guillain-Barré Syndrome (GBS) in India's Pune on Thursday (Jan 23). Around 12 out ...

As Maharashtra reports first death from the neurological condition, doctors explain the rise in cases, symptoms to watch for, ...

One person is believed to have died in India's Maharashtra state in an outbreak of Guillain-Barre syndrome (GBS) - a neurological disease that causes numbness, weakness and pain - and the number of ...

The second AI model, known as Brain MRI Enhancement foundation (BME-X), is designed to improve the overall quality of MRI ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...